Experienced in IgG4-Related Disease

Dr. David J. Iberri

Hematology | Hematology Oncology | Oncology
Stanford Health Care
300 Pasteur Dr, 
Stanford, CA 
Offers Telehealth

Experienced in IgG4-Related Disease
Stanford Health Care
300 Pasteur Dr, 
Stanford, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Iberri is a Hematologist and a Hematologist Oncology provider in Stanford, California. Dr. Iberri is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Multiple Myeloma, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Splenectomy.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Hematology Oncology
Oncology
Licenses
Internal Medicine in CA
Hospital Affiliations
Stanford Health Care Tri-Valley
Stanford Health Care
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Health Plan of San Mateo
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Santa Clara Family Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Valley Health
  • HMO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

STANFORD HEALTH CARE
300 Pasteur Dr, Stanford, CA 94305
Call: 650-723-4000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

A Phase I Study of Lenalidomide Therapy Prior to Re-induction Chemotherapy With Mitoxantrone, Etoposide, and Cytarabine (MEC) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML)
A Phase I Study of Lenalidomide Therapy Prior to Re-induction Chemotherapy With Mitoxantrone, Etoposide, and Cytarabine (MEC) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML)
Enrollment Status: Terminated
Publish Date: October 29, 2018
Intervention Type: Drug
Study Phase: Phase 1
A Phase 2 Study of Decitabine in Combination With Midostaurin (PKC412) for Elderly Patients With Newly Diagnosed FLT3-ITD/TKD Positive Acute Myeloid Leukemia
A Phase 2 Study of Decitabine in Combination With Midostaurin (PKC412) for Elderly Patients With Newly Diagnosed FLT3-ITD/TKD Positive Acute Myeloid Leukemia
Enrollment Status: Terminated
Publish Date: September 27, 2018
Intervention Type: Drug
Study Phase: Phase 2
An Open-Label Extension Study of Post-Transplant Maintenance Midostaurin (PKC412) in Elderly Patients (Age ≥ 60 Years) With FLT3-ITD/TKD Mutated AML Who Previously Received Midostaurin and Decitabine as Part of Study HEMAML0022 / CPKC412AUS27T
An Open-Label Extension Study of Post-Transplant Maintenance Midostaurin (PKC412) in Elderly Patients (Age ≥ 60 Years) With FLT3-ITD/TKD Mutated AML Who Previously Received Midostaurin and Decitabine as Part of Study HEMAML0022 / CPKC412AUS27T
Enrollment Status: Withdrawn
Publish Date: May 04, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

20 Total Publications

MGCS: where do we stand today?
MGCS: where do we stand today?
Journal: Hematology. American Society of Hematology. Education Program
Published: December 07, 2024
View All 20 Publications
Similar Doctors
Experienced in IgG4-Related Disease
Dr. Arpeet T. Shah
Oncology | Hematology | Hematology Oncology
Experienced in IgG4-Related Disease
Dr. Arpeet T. Shah
Oncology | Hematology | Hematology Oncology

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
 (0.1 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Arpeet Shah is an Oncologist and a Hematologist in Stanford, California. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Blood Clots, Thrombocytopenia, and Nephrectomy.

Experienced in IgG4-Related Disease
Dr. Elizabeth A. Odumakinde
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Elizabeth A. Odumakinde
Hematology Oncology | Hematology | Oncology

John Muir Physician Network

2571 Park Ave, 
Concord, CA 
 (38.9 miles away)
925-674-2100
Experience:
43+ years
Languages Spoken:
English, Yoruba
See accepted insurances

Elizabeth Odumakinde is a Hematologist Oncology specialist and a Hematologist in Concord, California. Dr. Odumakinde has been practicing medicine for over 43 years and is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, and Small Lymphocytic Lymphoma (SLL).

Experienced in IgG4-Related Disease
Dr. Anjali T. Sibley
Oncology | Hematology | Hematology Oncology
Experienced in IgG4-Related Disease
Dr. Anjali T. Sibley
Oncology | Hematology | Hematology Oncology

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
 (0.1 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Anjali Sibley is an Oncologist and a Hematologist in Stanford, California. Dr. Sibley is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Anemia, Adenoid Cystic Carcinoma, Acinic Cell Carcinoma of Salivary Glands, and Salivary Gland Tumors.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Iberri's expertise for a condition
ConditionClose
    • Distinguished
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Iberri is
      Distinguished
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Iberri is
      Distinguished
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Autoimmune Hemolytic Anemia
      Dr. Iberri is
      Distinguished
      . Learn about Autoimmune Hemolytic Anemia.
      See more Autoimmune Hemolytic Anemia experts
    • Chronic Lymphocytic Leukemia (CLL)
      Dr. Iberri is
      Distinguished
      . Learn about Chronic Lymphocytic Leukemia (CLL).
      See more Chronic Lymphocytic Leukemia (CLL) experts
    • Large-Cell Immunoblastic Lymphoma
      Dr. Iberri is
      Distinguished
      . Learn about Large-Cell Immunoblastic Lymphoma.
      See more Large-Cell Immunoblastic Lymphoma experts
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
      Dr. Iberri is
      Distinguished
      . Learn about Monoclonal Gammopathy of Undetermined Significance (MGUS).
      See more Monoclonal Gammopathy of Undetermined Significance (MGUS) experts
    View All 14 Distinguished Conditions
    • Advanced
    • Acute Eosinophilic Pneumonia
      Dr. Iberri is
      Advanced
      . Learn about Acute Eosinophilic Pneumonia.
      See more Acute Eosinophilic Pneumonia experts
    • Acute Mountain Sickness
      Dr. Iberri is
      Advanced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Iberri is
      Advanced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Adult Immune Thrombocytopenia
      Dr. Iberri is
      Advanced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • Agranulocytosis
      Dr. Iberri is
      Advanced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Anemia
      Dr. Iberri is
      Advanced
      . Learn about Anemia.
      See more Anemia experts
    View All 62 Advanced Conditions
    • Experienced
    • Acute Febrile Neutrophilic Dermatosis
      Dr. Iberri is
      Experienced
      . Learn about Acute Febrile Neutrophilic Dermatosis.
      See more Acute Febrile Neutrophilic Dermatosis experts
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Iberri is
      Experienced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Adult Soft Tissue Sarcoma
      Dr. Iberri is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Aleukemic Leukemia Cutis (ALC)
      Dr. Iberri is
      Experienced
      . Learn about Aleukemic Leukemia Cutis (ALC).
      See more Aleukemic Leukemia Cutis (ALC) experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Iberri is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Alveolar Soft Part Sarcoma
      Dr. Iberri is
      Experienced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    View All 110 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved